Clinical Trial Detail

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

NCT ID	NCT02538926
Title	Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride With Asparaginase in Treating Patients With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
Recruitment	Withdrawn
Gender	both
Phase	Phase II
Variant Requirements	Yes
Sponsors	University of Washington
Indications	lymphoma acute lymphoblastic leukemia
Therapies	Imatinib Rituximab Cyclophosphamide Prednisone Doxorubicin + Etoposide + Vincristine Sulfate Asparaginase
Age Groups:	adult
Covered Countries	USA